The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research. Br J Haematol 2010; 148 (5):739–753doi:10.1136/bmjspcare-2016-001204.30Turner, AndrewRoman, Eve
With centralised diagnostics at HMDS, Leeds and a unified clinical network covering a catchment population of ~4 million, the UK's population‐based Haematological Malignancy Research Network (www.hmrn.org) was established to provide timely real‐world data to answer such questions; and the ...
(2015) 112, 1575–1584 | doi: 10.1038/bjc.2015.94 Keywords: epidemiology; lymphoma; non-Hodgkin; Hodgkin; lymphoproliferative; cancer registration Lymphoma incidence, survival and prevalence 2004–2014: sub-type analyses from the UK's Haematological Malignancy Research Network A Smith1, S Crouch1, ...
EnglishEspañolDeutschFrançaisItalianoالعربية中文简体PolskiPortuguêsNederlandsNorskΕλληνικήРусскийTürkçeאנגלית 9 RegisterLog in Sign up with one click: Facebook Twitter Google Share on Facebook ...
The Haematological Malignancy Research Network (HMRN): a new information strategy for population based epidemiology and health service research The Haematological Malignancy Research Network (HMRN) was established in 2004 to provide robust generalizable data to inform clinical practice and research... A ...
FULL PAPER British Journal of Cancer (2013) 108, 2390–2398 | doi: 10.1038/bjc.2013.159 Keywords: cohort; height; body mass index; haematological malignancy; leukaemia; lymphoma Body size in relation to incidence of subtypes of haematological malignancy in the prospective Million Women Study F ...
Given the strong association between DNMT3A mutations and many types of haematological malignancy and the relatively poor understanding of its mechanistic function, DNMT3A represents an important new target for research and novel therapeutic approaches.Abstract...
The UK’s Haematological Malignancy Research Network (http://www.hmrn.org) routinely collects data on all patients newly diagnosed with myeloma, lymphoma and leukaemia (>2000 annually; population 3.6 million). With clinical agreement, patients are also invited to participate in an on-going survey...
Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network Ascertainment of cases and disease classification is an acknowledged problem for epidemiological research into haematological malignancies. The Haematologi... A Smith,D Howell,R Patmore,... - ...
haematological malignancy; immunotherapy; TKI; epigenetic modifiers; anti-angiogenic Abstract The recent and rapid development of molecularly targeted therapy is best illustrated by advances in the management of haematological malignancy. In myeloid diseases we have seen dramatic improvements in the overall ...